| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.022 | 0.9 |